INFINITY PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Inducement Grant Pursuant to NASDAQ Stock Market Rule 5635(c)(4)Stock Option Agreement • March 14th, 2017 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
AMENDED AND RESTATED LICENSE AGREEMENT BY AND BETWEEN INFINITY PHARMACEUTICALS, INC. AND VERASTEM, INC.License Agreement • March 14th, 2017 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Amended and Restated License Agreement (this “Agreement”) is entered into as the 1st day of November, 2016 and made effective as of the 29th day of October, 2016 (the “Effective Date”), by and between Infinity Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having a principal office located at 784 Memorial Drive, Cambridge, Massachusetts 02139 (“INFI”), and Verastem, Inc., a corporation organized and existing under the laws of Delaware, having a principal office located at 117 Kendrick Street, Suite 500, Needham, Massachusetts 02494 (“Licensee”). INFI and Licensee are each referred to herein by name or as a “Party” or, collectively, as “Parties.”
THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT.Infinity Pharmaceuticals, Inc. • March 14th, 2017 • Pharmaceutical preparations • Massachusetts
This letter (the “Agreement”) summarizes the terms of your separation from employment with Infinity Pharmaceuticals, Inc. (the “Company”). The purpose of this Agreement is to establish an amicable arrangement for ending your employment relationship, to release the Company from all legally waivable claims and to permit you to receive severance pay and other benefits described herein, under the terms of the applicable Infinity Pharmaceuticals, Inc. Severance Benefits Plan (the “Severance Benefits Plan”).
INFINITY PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • March 14th, 2017 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Infinity Pharmaceuticals, Inc. (the “Company”) has selected you to receive the following restricted stock award pursuant to its 2010 Stock Incentive Plan, as amended. The terms and conditions attached hereto are also a part hereof.
AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • March 14th, 2017 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of October 31, 2016, by and between ARE-770/784/790 MEMORIAL DRIVE, LLC, a Delaware limited liability company (“Landlord”), and INFINITY PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), with reference to the following:
THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT.Infinity Pharmaceuticals, Inc. • March 14th, 2017 • Pharmaceutical preparations • Massachusetts
This letter (the “Agreement”) summarizes the terms of your separation from employment with Infinity Pharmaceuticals, Inc. (the “Company”). The purpose of this Agreement is to establish an amicable arrangement for ending your employment relationship, to release the Company from all legally waivable claims and to permit you to receive severance pay and other benefits described herein, under the terms of the applicable Infinity Pharmaceuticals, Inc. Severance Benefits Plan (the “Severance Benefits Plan”).
